Benzinga | Nov 9, 2021 04:56PM EST

Organogenesis Holdings Q3 EPS $0.09 Beats $0.06 Estimate, Sales $113.80M Beat $112.67M Estimate

Organogenesis Holdings (NASDAQ:ORGO) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $0.06 by 50 percent. This is a 52.63 percent decrease over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $113.80 million which beat the analyst consensus estimate of $112.67 million by 1.00 percent. This is a 12.90 percent increase over sales of $100.80 million the same period last year.